NCT06293781 (ACTION) is a NA clinical trial of Web-based ACT in Major Depressive Disorder, sponsored by Gachon University.

Who is sponsoring NCT06293781?

NCT06293781 is sponsored by Gachon University.

What drugs are being tested in NCT06293781?

Interventions in NCT06293781: Web-based ACT, Treatment as usual.

What condition does NCT06293781 study?

NCT06293781 studies Major Depressive Disorder.

Is NCT06293781 still recruiting?

NCT06293781 is currently status unknown. Last updated 16 October 2024.

Last reviewed 2024-10-16 · How we verify

NCT06293781: ACTION

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Application of the Web-based Acceptance and Commitment Therapy for Depression

Status unknown NA Last updated 16 October 2024

What this trial tests

NA trial testing Web-based ACT in Major Depressive Disorder in 60 participants. Status unknown.

Timeline

19 December 2022

Primary endpoint
28 February 2025

28 February 2025

Quick facts

Lead sponsor	Gachon University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	19 December 2022
Primary completion	28 February 2025
Estimated completion	28 February 2025
Sites	1 location across South Korea

Drugs / interventions tested

Web-based ACT
Treatment as usual

Conditions studied

Major Depressive Disorder — all drugs for Major Depressive Disorder →

Sponsor

Gachon University

Who can join

Adults 19 to 65, any sex, with Major Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

PROSPECTIVE INTERVENTION STUDY; EFFICACY OF WEB-BASED ACCEPTANCE AND COMMITMENT THERAPY

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Major Depressive Disorder

Currently open trials in the same condition.

NCT07219394 — Peer-Delivered Behavioral Activation in a CCBHC · NA · recruiting
NCT06705478 — Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disor · Phase 2 · recruiting
NCT06749392 — An Individual-specific Synchrony Signature · NA · recruiting
NCT07316803 — Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness · NA · recruiting
NCT07242105 — Optimizing Brain Excitability in Depression · NA · recruiting

Other Gachon University trials

Trials by the same sponsor.

NCT03186599 — Analysis of Initial Adherence and Its Impact on Long-term Adherence to Hormonal Therapy for Breast Cancer · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06293781 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gachon University
Last refreshed: 16 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06293781.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing